- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Vector Science and Therapeutics Corp: Vector adds Jackson as managing director, corp. dev. | 4 | Stockwatch | ||
| Mo | Vector Science and Therapeutics Corp. Appoints Angus Jackson as Managing Director of Corporate Development | 1 | CNW | ||
| 14.10. | Vector Science and Therapeutics Corp: Vector Science appoints Starr as president | 1 | Stockwatch | ||
| 14.10. | Vector Science & Therapeutics Corp. Appoints Russell Starr as President | 1 | CNW | ||
| 14.10. | Vector Science appoints Russell Starr as president | 1 | Investing.com | ||
| 14.10. | Vector Science and Therapeutics Corp: Vector invests in Whoopi Wellness through SAFE | 1 | Stockwatch | ||
| 13.10. | Vector Science and Therapeutics Corp. Announces Collaboration and SAFE Investment in Whoopi Wellness, Inc. | 1 | CNW | ||
| 08.10. | Vector Science and Therapeutics Corp: Vector, Scoreboard to develop products for athletes | 1 | Stockwatch | ||
| VECTOR SCIENCE AND THERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| 07.10. | Vector Sciences & Therapeutics: Vector Science and Therapeutics Corp. Announces Collaboration with SAFE Investment in Gary Payton's Scoreboard | 201 | PR Newswire | Investment advances collaboration on peptide-based products for athletic performance, recovery and longevity
TORONTO, Oct. 7, 2026 /PRNewswire/ -- Vector Science... ► Artikel lesen | |
| 26.09. | Vector Science and Therapeutics Corp: Vector Science grants option to buy 150,000 shares | 3 | Stockwatch | ||
| 26.09. | Vector Science and Therapeutics Corp.: Vector Science and Therapeutics Corp. Issues Options | 1.078 | Newsfile | Mequon, Wisconsin--(Newsfile Corp. - September 25, 2026) - Vector Science and Therapeutics Corp. (TSXV: PAIN) ("Vector" or the "Company") today announced that the Board of Directors has approved the... ► Artikel lesen | |
| 26.08. | Vector Science and Therapeutics Corp. Enters Into an Investor Relations Agreement and Grants Options | 1 | CNW | ||
| 26.08. | Vector Science and Therapeutics Corp: Vector hires RedChip for investor relations services | 1 | Stockwatch | ||
| 24.08. | Vector Science & Therapeutics (TSXV: PAIN) Begins Peptide Production as First Suite at LyoGenesis Manufacturing Comes Online | 1 | CNW | ||
| 20.08. | Vector Science and Therapeutics Corp: Vector files patent for peptide orthopedic platform | 2 | Stockwatch | ||
| 20.08. | Vector Sciences & Therapeutics: Vector Science and Therapeutics Corp. (TSXV: PAIN) Files Provisional Patent Application on Integrated Platform for Orthopedic Tissue Regeneration Using Peptides | 248 | PR Newswire | Platform combines regenerative peptides with autologous platelet-rich biologics, alongside adjunct formulations designed to avoid interfering with the body's own... ► Artikel lesen | |
| 19.08. | Vector Science and Therapeutics Corp: Vector Science launches quality analytical testing | 1 | Stockwatch | ||
| 17.08. | Vector Science and Therapeutics Corp: Vector, LyoGenesis amend licence, manufacturing deal | 1 | Stockwatch | ||
| 17.08. | Vector Sciences & Therapeutics: Vector Science and Therapeutics Corp. Signs Amended, 10-Year Manufacturing and Testing Agreement with LyoGenesis Holdings | 237 | PR Newswire | Long-term agreement secures U.S.-based, cGMP manufacturing capacity for Vector's proprietary peptide platform, with quality testing performed by its affiliate Verlytix
... ► Artikel lesen | |
| 29.07. | Vector Science and Therapeutics Corp: Vector Science related company signs MOU with Wynn | 5 | Stockwatch |
1 2 3 Weiter >>
56 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 45,000 | +0,21 % | EQS-News: Fresenius SE & Co. KGaA: Aufsichtsrat beruft Dr. Marc-Alexander Mahl in den Vorstand und verlängert Vertrag von Sara Hennicken | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Personalie
Aufsichtsrat beruft Dr. Marc-Alexander Mahl in den Vorstand und verlängert Vertrag von Sara Hennicken (News mit Zusatzmaterial)
15.10.2026... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 41,440 | +1,00 % | RBC stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat das Kursziel für Siemens Healthineers von 45 auf 48 Euro angehoben und die Einstufung auf "Outperform" belassen. Der Start des neuen Strahlentherapiesystems... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,950 | -2,79 % | Fresenius Medical Care AG: Kurzfristige Gegenwinde zunehmend eingepreist; Hochstufung auf KAUFEN | Fresenius Medical Care (FME) hat die Prognose für das Geschäftsjahr 2026 bestätigt, wobei auslaufende TDAPA-Effekte, schwache Behandlungsvolumina in den USA und Restrukturierungsaufwendungen das Ergebnis... ► Artikel lesen | |
| HEARTFLOW | 55,62 | +0,05 % | Piper Sandler raises HeartFlow stock price target on competitive moat | ||
| PRIVIA HEALTH GROUP | 22,930 | 0,00 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen | |
| GERRESHEIMER | 32,760 | +0,12 % | EQS-News: Gerresheimer AG: Gerresheimer steigert EcoVadis-Ratingergebnis und wird erneut mit Gold ausgezeichnet | EQS-News: Gerresheimer AG
/ Schlagwort(e): Nachhaltigkeit/ESG
Gerresheimer steigert EcoVadis-Ratingergebnis und wird erneut mit Gold ausgezeichnet
14.10.2026 / 10:00 CET/CEST
Für... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 62,41 | -0,02 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 33,760 | +3,05 % | DEUTSCHE BANK RESEARCH stuft CARL ZEISS MEDITEC AG auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Carl Zeiss Meditec vor Zahlen auf "Hold" mit einem Kursziel von 26 Euro belassen. Das Medizintechnik-Unternehmen dürfte ein... ► Artikel lesen | |
| PROGYNY | 28,595 | +0,05 % | Progyny, Inc.: Progyny to Present New Menopause Research at The Menopause Society 2026 Annual Meeting | ||
| ALIGNMENT HEALTHCARE | 8,505 | -0,06 % | Alignment Healthcare USA, LLC: Alignment Health Plan and Astrana Health Partner to Expand Access to Trusted Local Care for California Seniors | ||
| KESTRA MEDICAL TECHNOLOGIES | 28,280 | 0,00 % | Kestra Medical Technologies: Evercore-Einstufung treibt Aktie vorbörslich an | ||
| BILLIONTOONE | 103,42 | 0,00 % | BillionToOne, Inc.: BillionToOne to Report Third Quarter 2026 Financial Results on November 4, 2026 | ||
| CONCENTRA GROUP | 38,770 | 0,00 % | Stephens initiates Concentra stock with overweight on health model | ||
| GENEDX | 68,81 | +0,10 % | GeneDx plans to add long-read genome sequencing to portfolio | ||
| LIFESTANCE HEALTH GROUP | 12,215 | -0,04 % | LifeStance Health Group, Inc. - 8-K, Current Report |
Das Unternehmen VECTOR SCIENCE AND THERAPEUTICS CORP kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VECTOR SCIENCE AND THERAPEUTICS CORP finden Sie auf Wallstreet Online.